Suppr超能文献

[门奇静脉断流术治疗门静脉高压症]

[Portazygos disconnection in the treatment of portal hypertension].

作者信息

Xue H Z, Jiang Q F, Tian J G

机构信息

Henan Provincial People's Hospital, Zhengzhou.

出版信息

Zhonghua Wai Ke Za Zhi. 1994 Oct;32(10):600-2.

PMID:7750417
Abstract

Since January 1988 to February 1993, 116 cases of cirrhotic portal hypertension were treated with portazygos disconnection. 37 cases were treated with Hassab's procedure, 36 cases were treated with amplification Hassab's procedure, 33 cases were treated with pericardial devascularization with circular interruption of blood flow of fundus, 10 cases were treated with transthoracic portazygos disconnection. The operative mortality was 6.9%. The hemorrhage rate was 8.6% in one month after the operation. All of 108 patients discharged from the hospital were followed up for 14 months to 75 months. The recurrent hemorrhage rate was 18.5% in the period. The one-year and three-year survival rate after the operation were 94.2% and 81.8%, respectively. The results we have got indicate that amplification Hassab's procedure and transthoracic portazygos disconnection have good effect.

摘要

自1988年1月至1993年2月,对116例肝硬化门静脉高压症患者施行了门奇断流术。其中37例行Hassab术,36例行改良Hassab术,33例行贲门周围血管离断加胃底血流环扎术,10例行经胸门奇断流术。手术死亡率为6.9%。术后1个月内再出血率为8.6%。108例出院患者均获随访,随访时间为14个月至75个月,此期间再出血率为18.5%。术后1年、3年生存率分别为94.2%和81.8%。结果表明,改良Hassab术和经胸门奇断流术效果良好。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验